Quantcast
Channel: Pharma Reform » marketing
Browsing latest articles
Browse All 20 View Live

Healthcare Market Perceptions create Expectations for Pharmaceutical Companies

The pharmaceutical industry has created market perceptions, right or wrong, that have been transformed into market expectations.   Like for any business meeting market expectations is a critical...

View Article



We Hate Your Financial Influence but we Like Your Money

A change of heart at Stanford Medical School allowed it to accept $3 million from Pfizer for CME after having publicly denounced the inappropriate financial influence of industry on CME. The draconian...

View Article

Who is Killing the Pharmaceutical Sales Position?

The role of the pharmaceutical sales representative (Chapter 9 in Pharmaplasia™) has been waning for some time.  The internet is full of discussions about the sales representative (“detail person”,...

View Article

Pharmaplasia™, Kindle Edition now available at Amazon.com

As word spreads and the popularity of Pharmaplasia increases so do the requests for more format options.  For those who have been waiting for the convenience of an e-book version of Pharmaplasia, it is...

View Article

Are Pharmaceutical Executives Hampering the Ability of their Companies to...

For professional representatives to flourish in the evolving new healthcare market executives must create a corporate environment that understands the importance of and is committed to changing the...

View Article


Have pharmaceutical representatives been expected to fill label claim and...

So what keeps representatives from having more engaging, more informative, and more credible discussions with physicians?  One of the most frequent reasons, or excuses, I hear about is the regulatory...

View Article

Time to Take Pharmaceutical Manufacturing Serious

It is alarming to see prominent pharmaceutical industry names in the headlines these days regarding manufacturing issues serious enough to require recalls and plant closings, and for the DOJ to be...

View Article

Why do Pharmaceutical Sales Representatives hate Scripted Sales Presentations?

For some pharmaceutical companies scripted sales presentations have become a necessity to assure compliance with Corporate Integrity Agreements.  For others it is a way to ensure consistent delivery of...

View Article


Deploying Pharmaceutical Sales Representatives to Drive Product Sales

So what would you do in the previously described post? If you wanted to continue the sales representative role, could you justify the expense and the return on investment? What would your justification...

View Article


Quit Blaming Drug Companies for Healthcare Market Prescribing and...

Pharmaceutical industry marketing and sales are often blamed for promoting  “off label” prescribing and have been highlighted in prescription drug fraud and product liability cases. If the healthcare...

View Article

Branded Prescription Drugs at Generic Drug Prices

Over 70% of prescriptions today are filled with generic drugs.  Once a branded product loses patent protection, they experience generic erosion and a rapid decline in market share of prescriptions....

View Article

The Clinical Pharmacist: A Powerful Role in Accountable Care Organizations

The clinical pharmacist has gradually evolved in influence from the early 1980’s to a new point of power with healthcare reform, especially in anticipation of Accountable Care Organizations.  While...

View Article

Successful Pharmaceutical Marketing needs the Support of Clinical Pharmacists

The increasingly influential role of clinical pharmacists in the evolving new healthcare market represents an opportunity for pharmaceutical marketers.   At the same time, to take advantage of this...

View Article


Pharmaceutical Industry Implications of Accountable Care Organization...

The Patient Protection and Affordable Care Act has prompted CMS (Centers for Medicare and Medicaid Services) in the US to draft a proposal for establishing Accountable Care Organizations (ACO’s).  This...

View Article

Getting Accountable Care Organizations to Promote your Prescription Drugs

In the previous post we discussed the CMS proposed ACO concept for developing healthcare provider systems that engage individual healthcare providers with “shared savings” incentives to improve the...

View Article


Healthcare Failure Statistics can Identify ACO Opportunities for...

When I first read through the 65 performance metrics outlined in the ACO draft proposal from CMS (Table 1, pages 174-194) it was easy to imagine how drug treatment could help healthcare providers in an...

View Article

Are Pharmaceutical Marketing and Sales Targeting Pharmacists?

In an earlier post we discussed the role of the clinical pharmacist in the evolving new healthcare market.  Medication therapy management as required by CMS as a part of Medicare Part D plans is a good...

View Article


Do Prescription Drugs Add to, Shift, or Reduce Healthcare Costs?

One would think that by implying your prescription drugs keep people healthy and out of the hospital you could also imply and conclude that drug treatment will lower overall healthcare costs for those...

View Article

Divining the Future from JP Morgan Healthcare Conference Presentations

The J P Morgan Healthcare Conference is, among other things, an annual four days of back to back 30 minute presentations by Pharma, biotech, device companies, CROs, and a diversity of healthcare...

View Article

How to Stop “Off-Label” Marketing and Sales of Prescription Drugs

I’m a little tired of reading about “off-label” promotion of prescription drugs, especially in the context of whistleblower instigated fraud cases and lawyer/patient driven product liability cases....

View Article
Browsing latest articles
Browse All 20 View Live




Latest Images